Weber MS - Search Results

1

B Cell-Directed Therapeutics in Multiple Sclerosis: Rationale and Clinical Evidence.

Kinzel S, Weber MS. Kinzel S, et al. Among authors: weber ms. CNS Drugs. 2016 Dec;30(12):1137-1148. doi: 10.1007/s40263-016-0396-6. CNS Drugs. 2016. PMID: 27844213 Review.

2

Pharmacological treatment of early multiple sclerosis.

Stüve O, Bennett JL, Hemmer B, Wiendl H, Racke MK, Bar-Or A, Hu W, Zivadinov R, Weber MS, Zamvil SS, Pacheco MF, Menge T, Hartung HP, Kieseier BC, Frohman EM. Stüve O, et al. Among authors: weber ms. Drugs. 2008;68(1):73-83. doi: 10.2165/00003495-200868010-00005. Drugs. 2008. PMID: 18081373 Review.

3

Disease-modifying agents for multiple sclerosis: recent advances and future prospects.

Menge T, Weber MS, Hemmer B, Kieseier BC, von Büdingen HC, Warnke C, Zamvil SS, Boster A, Khan O, Hartung HP, Stüve O. Menge T, et al. Among authors: weber ms. Drugs. 2008;68(17):2445-68. doi: 10.2165/0003495-200868170-00004. Drugs. 2008. PMID: 19016573 Review.

4

Cooperation of B cells and T cells in the pathogenesis of multiple sclerosis.

Weber MS, Hemmer B. Weber MS, et al. Results Probl Cell Differ. 2010;51:115-26. doi: 10.1007/400_2009_21. Results Probl Cell Differ. 2010. PMID: 19582406 Review.

5

The role of antibodies in multiple sclerosis.

Weber MS, Hemmer B, Cepok S. Weber MS, et al. Biochim Biophys Acta. 2011 Feb;1812(2):239-45. doi: 10.1016/j.bbadis.2010.06.009. Epub 2010 Jun 25. Biochim Biophys Acta. 2011. PMID: 20600871 Free article. Review.

6

The combination of interferon-beta and HMG-CoA reductase inhibition in multiple sclerosis: enthusiasm lost too soon?

Sellner J, Weber MS, Vollmar P, Mattle HP, Hemmer B, Stüve O. Sellner J, et al. Among authors: weber ms. CNS Neurosci Ther. 2010 Dec;16(6):362-73. doi: 10.1111/j.1755-5949.2010.00179.x. CNS Neurosci Ther. 2010. PMID: 20626428 Free PMC article. Review.

7

Glatiramer acetate in the treatment of multiple sclerosis: emerging concepts regarding its mechanism of action.

Lalive PH, Neuhaus O, Benkhoucha M, Burger D, Hohlfeld R, Zamvil SS, Weber MS. Lalive PH, et al. Among authors: weber ms. CNS Drugs. 2011 May;25(5):401-14. doi: 10.2165/11588120-000000000-00000. CNS Drugs. 2011. PMID: 21476611 Free PMC article. Review.

8

Current treatment strategies for multiple sclerosis - efficacy versus neurological adverse effects.

Weber MS, Menge T, Lehmann-Horn K, Kronsbein HC, Zettl U, Sellner J, Hemmer B, Stüve O. Weber MS, et al. Curr Pharm Des. 2012;18(2):209-19. doi: 10.2174/138161212799040501. Curr Pharm Des. 2012. PMID: 22229582 Review.

9

Developmental maturation of innate immune cell function correlates with susceptibility to central nervous system autoimmunity.

Hertzenberg D, Lehmann-Horn K, Kinzel S, Husterer V, Cravens PD, Kieseier BC, Hemmer B, Brück W, Zamvil SS, Stüve O, Weber MS. Hertzenberg D, et al. Among authors: weber ms. Eur J Immunol. 2013 Aug;43(8):2078-88. doi: 10.1002/eji.201343338. Epub 2013 Jun 3. Eur J Immunol. 2013. PMID: 23637087 Free PMC article.

10

Intrathecal anti-CD20 efficiently depletes meningeal B cells in CNS autoimmunity.

Lehmann-Horn K, Kinzel S, Feldmann L, Radelfahr F, Hemmer B, Traffehn S, Bernard CC, Stadelmann C, Brück W, Weber MS. Lehmann-Horn K, et al. Among authors: weber ms. Ann Clin Transl Neurol. 2014 Jul;1(7):490-6. doi: 10.1002/acn3.71. Epub 2014 Jul 3. Ann Clin Transl Neurol. 2014. PMID: 25356419 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

417 results

Search Page